Bradley Merrill Thompson, Member of the Firm in the Health Care and Life Sciences practice, in the firm’s Washington, DC, office, was quoted in FDA Week, in “2nd Cures Draft Pegs Low-Risk Software Exempt from FDA, but Gives Agency Some Latitude,” by Erin Durkin.

Following is an excerpt:

Bradley Thompson, an attorney at Epstein Becker & Green, said that while the second draft appears to include various perspectives from different stakeholders, he is concerned that some of the new language is difficult to interpret and may accidentally introduce more uncertainty into the process.

Thompson noted the January draft stated that clinical decision software would not be regulated so long as the software offered “the opportunity for additional interpretation or an independent confirmation” of the recommendations the software makes. He said that seemed pretty clear and easy to interpret.

But the second draft gives FDA discretion to determine whether a particular category of clinical decision software would pose significant risk to patient safety based on a “whole litany” of factors. “It would seem that the new process gives FDA quite a bit of latitude to decide what to regulate,” he said. “But the original purpose of this legislation was to more clearly define the dividing line between regulated and unregulated software.”

Thompson said that he would like to see sponsors adopt language that more clearly differentiates regulated from unregulated clinical decision software, “rather than simply kicking the ball back to FDA.”

Jump to Page

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.